Dulaglutide
Dulaglutide is a once-weekly GLP-1 receptor agonist with an Fc fusion domain studied for sustained incretin signaling and glycemic control. Research examines GLP-1R internalization, weight-loss kinetics, and cardiovascular outcome biomarkers in metabolic disease models.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
DL5
Peptide5mg × 10 vials (kit)
$150
DL10
Peptide10mg × 10 vials (kit)
$250
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord